| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... PLoS medicine 9 (8), e1001300, 2012 | 740 | 2012 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis TCG for the Meta, N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, ... The Lancet 392 (10150), 821-834, 2018 | 521 | 2018 |
| Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes D Falzon, N Gandhi, GB Migliori, G Sotgiu, HS Cox, TH Holtz, ... European Respiratory Journal 42 (1), 156-168, 2013 | 500 | 2013 |
| Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis MA Aziz, A Wright, A Laszlo, A De Muynck, F Portaels, A Van Deun, ... The Lancet 368 (9553), 2142-2154, 2006 | 453 | 2006 |
| Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates A Aubry, O Chosidow, E Caumes, J Robert, E Cambau Archives of Internal Medicine 162 (15), 1746, 2002 | 452 | 2002 |
| Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis GB Migliori, G Sotgiu, NR Gandhi, D Falzon, K DeRiemer, R Centis, ... European Respiratory Journal 42 (1), 169-179, 2013 | 325 | 2013 |
| The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit J Robert, SK Fridkin, HM Blumberg, B Anderson, N White, SM Ray, ... Infection Control and Hospital Epidemiology 21 (1), 12-17, 2000 | 314 | 2000 |
| Surveillance for control of antimicrobial resistance E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ... The Lancet Infectious Diseases 18 (3), e99-e106, 2018 | 305 | 2018 |
| Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact A Hartemann‐Heurtier, J Robert, S Jacqueminet, G Ha Van, JL Golmard, ... Diabetic Medicine 21 (7), 710-715, 2004 | 298 | 2004 |
| Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa Q Lu, J Yang, Z Liu, C Gutierrez, G Aymard, JJ Rouby, ... American journal of respiratory and critical care medicine 184 (1), 2012 | 289 | 2012 |
| Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains F Barbut, D Decre, V Lalande, B Burghoffer, L Noussair, A Gigandon, ... Journal of medical microbiology 54 (2), 181-185, 2005 | 273 | 2005 |
| Comparison of nine phenotypic methods for detection of extended-spectrum β-lactamase production by Enterobacteriaceae H Garrec, L Drieux-Rouzet, JL Golmard, V Jarlier, J Robert Journal of clinical microbiology 49 (3), 1048-1057, 2011 | 242 | 2011 |
| Compassionate use of bedaquiline for the treatment of MDR-and XDR-tuberculosis: an interim analysis of a French cohort L Guglielmetti, D Le Dû, M Jachym, B Henry, D Martin, E Caumes, ... Clinical Infectious Diseases, ciu786, 2014 | 210* | 2014 |
| Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa H Mouneimné, J Robert, V Jarlier, E Cambau Antimicrobial agents and chemotherapy 43 (1), 62-66, 1999 | 194 | 1999 |
| Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program V Jarlier, D Trystram, C Brun-Buisson, S Fournier, A Carbonne, L Marty, ... Archives of internal medicine 170 (6), 552, 2010 | 183 | 2010 |
| Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams E Weiss, JR Zahar, P Lesprit, E Ruppe, M Leone, J Chastre, JC Lucet, ... Clinical Microbiology and Infection 21 (7), 649. e1-649. e10, 2015 | 177 | 2015 |
| Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis L Guglielmetti, M Jaspard, D Le Dû, M Lachâtre, D Marigot-Outtandy, ... European Respiratory Journal 49 (3), 2017 | 161 | 2017 |
| Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs: an … ML Bastos, H Hussain, K Weyer, L Garcia-Garcia, V Leimane, CC Leung, ... Clinical Infectious Diseases, ciu619, 2014 | 158 | 2014 |
| Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study M Flament-Saillour, J Robert, V Jarlier, J GROSSET American journal of respiratory and critical care medicine 160 (2), 587-593, 1999 | 155 | 1999 |
| A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study TM Walker, M Merker, AM Knoblauch, P Helbling, OD Schoch, ... The Lancet Infectious Diseases 18 (4), 431-440, 2018 | 152 | 2018 |
